Amneal Pharmaceuticals, Class Stock Price History
| AMRX Stock | USD 8.67 0.22 2.47% |
Below is the normalized historical share price chart for Amneal Pharmaceuticals, Class extending back to January 14, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Amneal Pharmaceuticals, stands at 8.67, as last reported on the 25th of March, with the highest price reaching 8.66 and the lowest price hitting 8.66 during the day.
If you're considering investing in Amneal Stock, it is important to understand the factors that can impact its price. Amneal Pharmaceuticals, appears to be not too volatile, given 3 months investment horizon. Amneal Pharmaceuticals, secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Amneal Pharmaceuticals, Class, which you can use to evaluate the volatility of the firm. Please makes use of Amneal Pharmaceuticals,'s Mean Deviation of 1.55, risk adjusted performance of 0.1067, and Downside Deviation of 1.98 to double-check if our risk estimates are consistent with your expectations.
At this time, Amneal Pharmaceuticals,'s Common Stock is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.9 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 168.6 M in 2025. . At this time, Amneal Pharmaceuticals,'s Price Earnings To Growth Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 10.57 in 2025, whereas Price To Sales Ratio is likely to drop 0.83 in 2025. Amneal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of January 2009 | 200 Day MA 8.0533 | 50 Day MA 8.394 | Beta 1.05 |
Amneal |
Sharpe Ratio = 0.1157
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AMRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.99 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Amneal Pharmaceuticals, is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amneal Pharmaceuticals, by adding it to a well-diversified portfolio.
Price Book 86.1038 | Enterprise Value Ebitda 11.7455 | Price Sales 1.4703 | Shares Float 157.8 M | Wall Street Target Price 11.5 |
Amneal Pharmaceuticals, Stock Price History Chart
There are several ways to analyze Amneal Stock price data. The simplest method is using a basic Amneal candlestick price chart, which shows Amneal Pharmaceuticals, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 20, 2025 | 9.01 |
| Lowest Price | January 13, 2025 | 7.72 |
Amneal Pharmaceuticals, March 25, 2025 Stock Price Synopsis
Various analyses of Amneal Pharmaceuticals,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Amneal Stock. It can be used to describe the percentage change in the price of Amneal Pharmaceuticals, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Amneal Stock.| Amneal Pharmaceuticals, Price Rate Of Daily Change | 0.98 | |
| Amneal Pharmaceuticals, Price Action Indicator | (0.10) |
Amneal Pharmaceuticals, March 25, 2025 Stock Price Analysis
Amneal Stock Price History Data
The price series of Amneal Pharmaceuticals, for the period between Wed, Dec 25, 2024 and Tue, Mar 25, 2025 has a statistical range of 1.32 with a coefficient of variation of 5.21. The prices are distributed with arithmetic mean of 8.26. The median price for the last 90 days is 8.22.| Open | High | Low | Close | Volume | ||
03/25/2025 | 8.89 | 8.66 | 8.66 | 8.66 | ||
| 03/24/2025 | 8.76 | 8.92 | 8.71 | 8.89 | 1,104,578 | |
| 03/21/2025 | 8.88 | 9.00 | 8.65 | 8.66 | 1,867,099 | |
| 03/20/2025 | 8.73 | 9.04 | 8.63 | 9.01 | 2,337,600 | |
| 03/19/2025 | 8.62 | 8.78 | 8.62 | 8.73 | 1,504,120 | |
| 03/18/2025 | 8.58 | 8.74 | 8.32 | 8.62 | 1,705,600 | |
| 03/17/2025 | 8.75 | 8.84 | 8.60 | 8.62 | 1,618,875 | |
| 03/14/2025 | 8.84 | 8.95 | 8.72 | 8.75 | 4,647,087 | |
| 03/13/2025 | 8.88 | 9.10 | 8.78 | 8.79 | 1,904,670 | |
| 03/12/2025 | 8.77 | 8.92 | 8.71 | 8.88 | 1,830,615 | |
| 03/11/2025 | 8.67 | 8.97 | 8.65 | 8.84 | 1,009,823 | |
| 03/10/2025 | 8.70 | 8.89 | 8.57 | 8.70 | 1,453,441 | |
| 03/07/2025 | 8.75 | 8.99 | 8.56 | 8.90 | 1,926,975 | |
| 03/06/2025 | 8.75 | 8.85 | 8.61 | 8.76 | 2,448,940 | |
| 03/05/2025 | 8.77 | 9.00 | 8.62 | 8.97 | 2,221,273 | |
| 03/04/2025 | 8.72 | 9.01 | 8.64 | 8.84 | 1,757,298 | |
| 03/03/2025 | 8.69 | 9.16 | 8.68 | 8.76 | 2,670,000 | |
| 02/28/2025 | 7.87 | 8.70 | 7.61 | 8.67 | 2,847,924 | |
| 02/27/2025 | 8.48 | 8.66 | 8.32 | 8.38 | 1,683,719 | |
| 02/26/2025 | 8.49 | 8.60 | 8.04 | 8.43 | 3,331,573 | |
| 02/25/2025 | 8.40 | 8.51 | 8.27 | 8.50 | 1,173,992 | |
| 02/24/2025 | 8.49 | 8.79 | 8.21 | 8.30 | 4,299,604 | |
| 02/21/2025 | 7.92 | 7.94 | 7.74 | 7.83 | 1,280,866 | |
| 02/20/2025 | 7.81 | 7.88 | 7.68 | 7.87 | 969,751 | |
| 02/19/2025 | 7.74 | 7.95 | 7.66 | 7.85 | 905,558 | |
| 02/18/2025 | 7.71 | 7.80 | 7.71 | 7.79 | 530,455 | |
| 02/14/2025 | 7.91 | 7.92 | 7.69 | 7.73 | 438,486 | |
| 02/13/2025 | 7.86 | 7.93 | 7.80 | 7.91 | 595,400 | |
| 02/12/2025 | 7.84 | 7.95 | 7.81 | 7.82 | 559,348 | |
| 02/11/2025 | 7.87 | 8.02 | 7.82 | 7.96 | 631,823 | |
| 02/10/2025 | 7.90 | 8.04 | 7.64 | 7.95 | 1,421,100 | |
| 02/07/2025 | 7.89 | 7.96 | 7.83 | 7.85 | 803,176 | |
| 02/06/2025 | 7.98 | 8.07 | 7.86 | 7.97 | 1,377,377 | |
| 02/05/2025 | 8.03 | 8.20 | 7.91 | 7.98 | 1,778,082 | |
| 02/04/2025 | 8.13 | 8.16 | 7.96 | 7.99 | 1,723,400 | |
| 02/03/2025 | 8.09 | 8.28 | 8.01 | 8.18 | 1,166,900 | |
| 01/31/2025 | 8.57 | 8.67 | 8.24 | 8.26 | 1,244,700 | |
| 01/30/2025 | 8.79 | 8.85 | 8.56 | 8.58 | 1,632,600 | |
| 01/29/2025 | 8.69 | 8.79 | 8.65 | 8.73 | 624,900 | |
| 01/28/2025 | 8.83 | 8.88 | 8.65 | 8.73 | 589,300 | |
| 01/27/2025 | 8.65 | 8.86 | 8.61 | 8.82 | 1,134,900 | |
| 01/24/2025 | 8.77 | 8.82 | 8.54 | 8.68 | 767,200 | |
| 01/23/2025 | 8.45 | 9.05 | 8.42 | 8.81 | 1,631,700 | |
| 01/22/2025 | 8.61 | 8.61 | 8.38 | 8.52 | 851,500 | |
| 01/21/2025 | 8.34 | 8.59 | 8.28 | 8.56 | 2,206,200 | |
| 01/17/2025 | 8.35 | 8.38 | 8.16 | 8.26 | 1,109,500 | |
| 01/16/2025 | 8.20 | 8.42 | 8.12 | 8.31 | 1,452,700 | |
| 01/15/2025 | 8.01 | 8.25 | 7.89 | 8.22 | 1,503,400 | |
| 01/14/2025 | 7.73 | 7.88 | 7.69 | 7.85 | 848,200 | |
| 01/13/2025 | 7.87 | 7.96 | 7.69 | 7.72 | 1,486,000 | |
| 01/10/2025 | 8.02 | 8.02 | 7.82 | 7.97 | 662,700 | |
| 01/08/2025 | 8.00 | 8.07 | 7.79 | 8.06 | 1,447,900 | |
| 01/07/2025 | 7.78 | 7.88 | 7.63 | 7.87 | 1,038,500 | |
| 01/06/2025 | 7.82 | 7.88 | 7.72 | 7.77 | 1,020,500 | |
| 01/03/2025 | 7.76 | 7.87 | 7.69 | 7.82 | 778,200 | |
| 01/02/2025 | 7.93 | 8.07 | 7.71 | 7.76 | 1,051,600 | |
| 12/31/2024 | 7.85 | 8.01 | 7.72 | 7.92 | 1,685,100 | |
| 12/30/2024 | 7.74 | 7.87 | 7.63 | 7.83 | 981,600 | |
| 12/27/2024 | 7.77 | 7.83 | 7.65 | 7.82 | 933,600 | |
| 12/26/2024 | 7.81 | 7.86 | 7.64 | 7.85 | 507,100 | |
| 12/24/2024 | 7.79 | 7.85 | 7.71 | 7.85 | 353,800 |
About Amneal Pharmaceuticals, Stock history
Amneal Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Amneal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Amneal Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Amneal Pharmaceuticals, stock prices may prove useful in developing a viable investing in Amneal Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 309 M | 168.6 M | |
| Net Loss | -117 M | -111.1 M |
Amneal Pharmaceuticals, Quarterly Net Working Capital |
|
Amneal Pharmaceuticals, Stock Technical Analysis
Amneal Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Amneal Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Amneal Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of Amneal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Amneal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1067 | |||
| Jensen Alpha | 0.2395 | |||
| Total Risk Alpha | 0.301 | |||
| Sortino Ratio | 0.1288 | |||
| Treynor Ratio | 0.3805 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.